Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last SFr.10.15 CHF
Change Today +0.05 / 0.50%
Volume 40.6K
SHLTN On Other Exchanges
SIX Swiss Ex
As of 11:43 AM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

shl telemedicine ltd-reg (SHLTN) Snapshot

Previous Close
Day High
Day Low
52 Week High
05/12/15 - SFr.11.25
52 Week Low
08/4/14 - SFr.7.05
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

shl telemedicine ltd-reg (SHLTN) Related Businessweek News

No Related Businessweek News Found

shl telemedicine ltd-reg (SHLTN) Details

SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine systems in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12-lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter that transmits a patient's complete 12-lead ECG and rhythm read-out strip in real-time to support professional evaluation of medical conditions; Cardio'B, a portable device, which transmits a 12-lead ECG; and CardioBeeper 12/12, a hand-held ECG transmitter device for personal use that transmits a full ECG reading to the monitoring center. The company also provides central communication module, a telecommunication device that transmits medical data to its telemedicine centers from various medical monitoring devices; TeleWeight, a trans-telephonic weight monitoring device for personal use; TelePress, a remote blood pressure monitoring device for personal use; TeleBreather, a remote, electronic, handheld device to test how well the lungs are working; and TelePulse Oximeter, an electronic, handheld diagnostic device to measure the saturation level of oxygen in blood and pulse rate. In addition, it offers medical call center services with a focus on cardiovascular and related diseases to end users, as well as to the healthcare community. The company offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. It serves patients, health insurance companies, hospitals, clinics, physicians, and other health care providers. The company was founded in 1987 and is headquartered in Tel Aviv, Israel.

448 Employees
Last Reported Date: 03/25/15
Founded in 1987

shl telemedicine ltd-reg (SHLTN) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

shl telemedicine ltd-reg (SHLTN) Key Developments

SHL Telemedicine Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2015

SHL Telemedicine Ltd. reported earnings results for the first quarter ended March 31, 2015. Revenues for the first quarter amounted to USD 9.5 million compared with USD 10.6 million in the first quarter of 2014, a decrease of 10.4%. At constant exchange rates revenues were USD 11.1 million, up 4.7%. EBITDA for the quarter amounted to USD 2.6 million with EBIT for the quarter amounting to USD 1.3 million compared with EBITDA of USD 2.0 million and EBIT of USD 0.4 million in the first quarter of 2014. Net income for the quarter amounted to USD 1.4 million or USD 0.14 per share compared with USD 0.0 million in first quarter of 2014. Cash used in operations in the quarter was USD 0.6 million compared to cash used in operations of USD 2.4 million in the first quarter of 2014.

SHL Telemedicine Ltd., Q1 2015 Earnings Call, May 28, 2015

SHL Telemedicine Ltd., Q1 2015 Earnings Call, May 28, 2015

SHL Telemedicine Signs Distribution Agreement for the smartheart(TM) Device with FUJIFILM SonoSite

SHL Telemedicine Ltd. announced it has signed an international distribution agreement for its innovative smartheart(TM) device with FUJIFILM SonoSite, Inc. smartheart(TM) is the first and only personal mobile 12-lead ECG device on the market that enables the detection of heart attacks. FUJIFILM SonoSite will distribute the smartheart(TM) device to its professional healthcare customers in the US, Japan and Germany, using its point-of-care ultrasound solutions. With smartheart and a smartphone or tablet they can perform a full hospital grade ECG and send it to a clinic, a hospital or SHL's telemedicine center for diagnosis.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SHLTN:SW SFr.10.15 CHF +0.05

SHLTN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
BioTelemetry Inc $12.23 USD +0.54
Health Revenue Assurance Holdings Inc $0.0015 USD -0.0003
LifeWatch AG SFr.16.10 CHF -0.20
View Industry Companies

Industry Analysis


Industry Average

Valuation SHLTN Industry Range
Price/Earnings 47.4x
Price/Sales 2.7x
Price/Book 1.8x
Price/Cash Flow 25.4x
TEV/Sales 2.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHL TELEMEDICINE LTD-REG, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at